This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2vr3
From Proteopedia
| Line 1: | Line 1: | ||
| - | [[Image:2vr3.png|left|200px]] | ||
| - | |||
{{STRUCTURE_2vr3| PDB=2vr3 | SCENE= }} | {{STRUCTURE_2vr3| PDB=2vr3 | SCENE= }} | ||
| - | |||
===STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF FIBRINOGEN BINDING TO CLFA FROM STAPHYLOCCCUS AUREUS=== | ===STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF FIBRINOGEN BINDING TO CLFA FROM STAPHYLOCCCUS AUREUS=== | ||
| + | {{ABSTRACT_PUBMED_19043557}} | ||
| - | + | ==Disease== | |
| + | [[http://www.uniprot.org/uniprot/FIBG_HUMAN FIBG_HUMAN]] Defects in FGG are a cause of congenital afibrinogenemia (CAFBN) [MIM:[http://omim.org/entry/202400 202400]]. This rare autosomal recessive disorder is characterized by bleeding that varies from mild to severe and by complete absence or extremely low levels of plasma and platelet fibrinogen. Note=Patients with congenital fibrinogen abnormalities can manifest different clinical pictures. Some cases are clinically silent, some show a tendency toward bleeding and some show a predisposition for thrombosis with or without bleeding. | ||
| + | |||
| + | ==Function== | ||
| + | [[http://www.uniprot.org/uniprot/FIBG_HUMAN FIBG_HUMAN]] Fibrinogen has a double function: yielding monomers that polymerize into fibrin and acting as a cofactor in platelet aggregation. | ||
==About this Structure== | ==About this Structure== | ||
| Line 12: | Line 14: | ||
==See Also== | ==See Also== | ||
*[[Fibrinogen|Fibrinogen]] | *[[Fibrinogen|Fibrinogen]] | ||
| + | *[[Fibrinogen binding protein|Fibrinogen binding protein]] | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:019043557</ref><references group="xtra"/> | + | <ref group="xtra">PMID:019043557</ref><references group="xtra"/><references/> |
[[Category: Staphylococcus aureus]] | [[Category: Staphylococcus aureus]] | ||
[[Category: Bowden, M G.]] | [[Category: Bowden, M G.]] | ||
Revision as of 04:15, 25 March 2013
Contents |
STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF FIBRINOGEN BINDING TO CLFA FROM STAPHYLOCCCUS AUREUS
Template:ABSTRACT PUBMED 19043557
Disease
[FIBG_HUMAN] Defects in FGG are a cause of congenital afibrinogenemia (CAFBN) [MIM:202400]. This rare autosomal recessive disorder is characterized by bleeding that varies from mild to severe and by complete absence or extremely low levels of plasma and platelet fibrinogen. Note=Patients with congenital fibrinogen abnormalities can manifest different clinical pictures. Some cases are clinically silent, some show a tendency toward bleeding and some show a predisposition for thrombosis with or without bleeding.
Function
[FIBG_HUMAN] Fibrinogen has a double function: yielding monomers that polymerize into fibrin and acting as a cofactor in platelet aggregation.
About this Structure
2vr3 is a 4 chain structure with sequence from Staphylococcus aureus. Full crystallographic information is available from OCA.
See Also
Reference
- Ganesh VK, Rivera JJ, Smeds E, Ko YP, Bowden MG, Wann ER, Gurusiddappa S, Fitzgerald JR, Hook M. A structural model of the Staphylococcus aureus ClfA-fibrinogen interaction opens new avenues for the design of anti-staphylococcal therapeutics. PLoS Pathog. 2008 Nov;4(11):e1000226. Epub 2008 Nov 28. PMID:19043557 doi:10.1371/journal.ppat.1000226
